Previous symbols: XPF. Aliases: RAD1, FANCQ.
ERCC4/XPF is the catalytic subunit of the ERCC1-XPF structure-specific DNA endonuclease, a Mg2+-dependent nuclease that cleaves DNA at single-stranded/ double-stranded junctions and makes the incision 5' to a lesion on the damaged strand. XPF houses the nuclease active site (N-terminal helicase-like/nuclease region), while its obligate partner ERCC1 (bound through the C-terminal double helix-hairpin-helix domain) contributes additional DNA binding but is catalytically inert. As the enzyme that makes the 5' incision, ERCC1-XPF is essential for nucleotide excision repair (NER), where it is recruited to lesions via XPA and, together with the 3'-incising ERCC5/XPG nuclease, excises the damage-containing oligonucleotide. The same structure-specific endonuclease performs the unhooking incisions that release DNA interstrand crosslinks (ICLs), where it is coordinated by SLX4/FANCP, and it processes recombination intermediates in homology-directed pathways including single-strand annealing (acting on 3' non-homologous flaps, stimulated by RAD52). ERCC1-XPF also acts at telomeres, removing the 3' single-stranded overhang from uncapped telomeres and negatively regulating telomere length. The enzyme localizes to the nucleus and to chromatin sites of DNA damage. Loss of XPF function underlies a spectrum of human disease that all reflects the same endonuclease deficiency - xeroderma pigmentosum group F, XPF-Cockayne syndrome, XFE progeroid syndrome, and Fanconi anemia complementation group Q.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Xeroderma Pigmentosum | causative germline |
mechanism: Impaired nucleotide-excision repair
subtype: XP-F
scoped to subtype: XP-F
|
| XFE Progeroid Syndrome | causative partial loss of function |
mechanism: Biallelic Hypomorphic ERCC4 Variants
|
| Fanconi_Anemia |
untyped
Pathogenic Variants
|
mechanism: Downstream Effector Dysfunction
subtype: FA-Q
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| xeroderma pigmentosum group F MONDO:0010215 | AR | Definitive 2019-08-14 |
Xeroderma Pigmentosum
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.